Company: Lacerta Therapeutics, Inc.
Job title: Chief Scientific Officer
Exploring the Optimal Way to Measure & Monitor AAV Safety Signals in the CNS 9:30 am
• Assessing the accuracy of imaging technology to inform on the AAV safety profile • Identifying novel strategies to facilitate monitoring by using biomarkers • Investigating CNS gene therapy deliver method to minimize safety eventsRead more
day: Day Two
Panel Discussion: Understanding the Pitfalls Associated with Monkey Models 1:30 pm
• Assessing the mechanism for how monkeys manifest toxicity in response to AAV vectors • Elucidating the mechanism for how liver damage occurs in monkeys • Exploring the differences between the monkey and human cellular immune response to better inform AAV safety understandingRead more
day: Day One